Source link : https://www.newshealth.biz/health-news/long-acting-cabotegravir-appears-safe-in-pregnancy/
HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir (CAB-LA; Apretude) appeared safe during pregnancy among cisgender women, according to an analysis of the HPTN 084 open-label extension trial. Composite poor pregnancy outcomes were reported in 33% of pregnancies with active CAB-LA use, 38% with prior CAB-LA use, and 27% with no previous or active CAB-LA […]
Author : News Health
Publish date : 2024-07-25 21:05:35
Copyright for syndicated content belongs to the linked Source.
Categories